Facebook
Instagram
Linkedin
Pinterest
Reddit
Twitter
Youtube
Sign in
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk (Dairy) Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons & Offers
Resources
Newsletter
SnackSafely Manufacturer Partnership
Take 2 Epinephrine Reminder Flyers
Put Your School on the Map
About Us
SnackSafely Media Kit
SnackSafely Advertising Guide
Terms and Conditions
Privacy Policy
Contact Us
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Terms and Conditions
Password recovery
Recover your password
your email
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk (Dairy) Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons & Offers
Resources
Newsletter
SnackSafely Manufacturer Partnership
Take 2 Epinephrine Reminder Flyers
Put Your School on the Map
About Us
SnackSafely Media Kit
SnackSafely Advertising Guide
Terms and Conditions
Privacy Policy
Contact Us
Search
Home
Emerging Therapy
Page 21
Emerging Therapy
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase II Trial Now Recruiting, Investigates Microbiome as Immunotherapy Enhancer
Dave Bloom
-
2025/11/21
Anaphylm™ Sublingual Epinephrine Shows Promising Results for Pediatric Anaphylaxis Treatment
Peanut Patch Treatment Continues to Help Toddlers Safely Build Tolerance Over Three Years
Peanut Sublingual Immunotherapy Shows Long-Term Benefits for Young Children
RAPT Therapeutics Launches Phase 2b Trial for Anti-IgE Therapy for Food Allergies
FDA to Hold Open Advisory Meeting on AR101 Peanut Allergy OIT...
Dave Bloom
-
2019/08/19
0
DBV Technologies Submits Biologics License Application to FDA for Viaskin Peanut...
News Wire ~ 3rd Party Press Release
-
2019/08/08
0
Clinical Trial to Evaluate Experimental Treatment in People Allergic to Multiple...
News Wire ~ 3rd Party Press Release
-
2019/08/01
0
Vedanta Biosciences Announces First Patient Enrolled in VE416 Phase 1b/2 Food...
News Wire ~ 3rd Party Press Release
-
2019/07/02
0
Aravax Presents Additional Positive Phase I Trial Results for PVX108, a...
News Wire ~ 3rd Party Press Release
-
2019/06/05
0
Phase 3 Trial Data Demonstrates Consistent Safety and Efficacy of AR101...
Dave Bloom
-
2019/06/03
0
Aimmune Announces US FDA Advisory Committee Meeting Date for AR101 for...
News Wire ~ 3rd Party Press Release
-
2019/05/16
0
Study: Peanut OIT Increases Allergic Reactions, Compared with Avoidance or Placebo
News Wire ~ 3rd Party Press Release
-
2019/04/26
0
Must Hear: Interview with Stanford Immunologist Dr Kari Nadeau – Defeating...
Dave Bloom
-
2019/04/09
0
Researchers Develop First Functional Targeted Inhibitors of Peanut Allergens
News Wire ~ 3rd Party Press Release
-
2019/04/08
0
1
...
20
21
22
...
30
Page 21 of 30